Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines

By Holford J.   Beale P.J.   Boxall F.E.   Sharp S.Y.   Kelland L.R.  

European Journal of Cancer, Vol. 36, Iss. 15, 2000-10 ,pp. : 1984-1990

Elsevier

Access to resources Recommend Favorite

A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine

By Flaherty Keith   Stevenson James   Redlinger Maryann   Algazy Kenneth   Giantonio Bruce   O’Dwyer Peter  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 404-408

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer

By Rader J.S.   Clarke-Pearson D.   Moore M.   Carson L.   Holloway R.   Kao M.-S.   Wiznitzer I.   Douglass E.C.  

Gynecologic Oncology, Vol. 91, Iss. 2, 2003-11 ,pp. : 318-325

Elsevier

Access to resources Recommend Favorite

Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)

By Koinis Filippos   Polyzos Aristidis   Christopoulou Athina   Zafeiriou Zafeiris   Emmanouilidis Christos   Papadimitraki Elisavet   Kalykaki Antonia   Kalbakis Kostas   Samonis George   Georgoulias Vassilis  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 819-825

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of Paclitaxel in Platinum Pretreated Ovarian Cancer. A Hellenic Cooperative Oncology Group Study

By Aravantinos G.   Skarlos D.V.   Kosmidis P.   Athanassiades A.   Bafaloukos D.   Giannakakis T.   Karpathios S.   Fountzilas G.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 160-163

Elsevier

Access to resources Recommend Favorite